📰 Discovery Engine News
Page 2 - Discovery Engine News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Discovery Engine. Real-time updates on events, politics, business and more.
November 15, 2023
Have you ever seen your daughter’s bedroom and wondered what was missing? Perhaps it’s the absence of a charming headboard that would transform her space into a dreamy haven. It would be very exciting for her if she found a bed that fit snugly for a princess when she woke up. How did you make […]
October 22, 2023
Presentation Operator MessageOperator Hello, and welcome to the ESMO Data Presentation. [Operator Instructions] Please be advised that todays conference is being recorded.It is now my pleasure to...
October 22, 2023
– Data presented at the European Society for Medical Oncology from the Phase 1/2 trial with bavdegalutamide showed 11.1 months radiographic progression free survival in mCRPC patients with tumors harboring
October 22, 2023
– Data presented at the European Society for Medical Oncology from the Phase 1/2 trial with bavdegalutamide showed 11.1 months radiographic progression free survival in mCRPC patients with tumors...
October 16, 2023
NEW HAVEN, Conn., Oct. 15, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...
October 16, 2023
NEW HAVEN, Conn. and NEW YORK, Oct. 15, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ:ARVN) and Pfizer Inc. (NYSE:PFE) today announced they will present updated Phase 1/2 data for vepdegestrant (ARV-471) at the 2023
October 15, 2023
NEW HAVEN, Conn., Oct. 15, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced it will present updated Phase 1/2 trial data for bavdegalutamide (ARV-110) at the 2023 European Society for Medical Oncology (ESMO) Annual Congress. Bavdegalutamide is an investigational orally bioavailable PROTAC® androgen receptor (AR) degrader and is being developed as a potential trea...
October 15, 2023
NEW HAVEN, Conn. and NEW YORK, Oct. 15, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced they will...
October 15, 2023
NEW HAVEN, Conn. and NEW YORK, Oct. 15, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced they w...
October 6, 2023
A good LED TV assures you of high definition television experience like no other. Check our our September 2023 list of latest LED TVs available on Amazon.